Invesaro

Stocks LIPO Earnings

Earnings

Lipella Pharmaceuticals Inc. (LIPO) earnings

Quarterly results of Lipella Pharmaceuticals Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when LIPO files with the SEC.

Latest quarter: Q3 FY2025

In Q3 FY2025 (ended September 30, 2025) Lipella Pharmaceuticals Inc. reported revenue of - and a net loss of $1.3M.

Diluted earnings per share were -$0.28.

Filed with the SEC on November 14, 2025.

Revenue by quarter
Q4 23: $120.8K $120.8K Q4 23Q1 24: $145.9K $145.9K Q1 24Q2 24: $136.4K $136.4K Q2 24Q3 24: $80.4K $80.4K Q3 24Q4 24: $173.7K $173.7K Q4 24Q1 25: $129.4K $129.4K Q1 25Q2 25: $86.7K $86.7K Q2 25
Net income by quarter
Q4 23: -$688.9K -$688.9K Q4 23Q1 24: -$1.2M -$1.2M Q1 24Q2 24: -$938.1K -$938.1K Q2 24Q3 24: -$1.4M -$1.4M Q3 24Q4 24: -$1.4M -$1.4M Q4 24Q1 25: -$1.3M -$1.3M Q1 25Q2 25: -$1.3M -$1.3M Q2 25Q3 25: -$1.3M -$1.3M Q3 25

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q3 FY2025September 30, 2025---$1.3M-$0.28
Q2 FY2025June 30, 2025$86.7K-36.4%-$1.3M-$0.31
Q1 FY2025March 31, 2025$129.4K-11.3%-$1.3M-$0.64
Q4 FY2024December 31, 2024$173.7K+43.7%-$1.4M-
Q3 FY2024September 30, 2024$80.4K--$1.4M-$1.29
Q2 FY2024June 30, 2024$136.4K--$938.1K-$0.99
Q1 FY2024March 31, 2024$145.9K--$1.2M-$1.31
Q4 FY2023December 31, 2023$120.8K--$688.9K-

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

Get an email when LIPO reports

Follow LIPO and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when LIPO files with the SEC.

Source: quarterly figures Lipella Pharmaceuticals Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Lipella Pharmaceuticals Inc.